Table 1 Baseline clinical and pathologic characteristics.
From: Polygenic risk score for tumor aggressiveness and early-onset prostate cancer in Asians
Groups by percentile | All | < 25 | 25–50 | 50–75 | ≥ 75 | p-value |
|---|---|---|---|---|---|---|
Age (years), mean ± SD | 67.3 ± 7.6 | 67.1 ± 7.5 | 67.8 ± 7.7 | 67.5 ± 7.6 | 66.8 ± 7.6 | 0.036 |
BMI (kg/m2), mean ± SD | 24.5 ± 2.7 | 24.6 ± 2.7 | 24.4 ± 2.8 | 24.4 ± 2.5 | 24.7 ± 2.9 | 0.435 |
PSA (ng/ml), mean ± SD | 29.8 ± 192.2 | 19.0 ± 63.6 | 25.1 ± 109.2 | 37.7 ± 206.9 | 37.0 ± 294.6 | 0.116 |
Grade group (%) | 0.052 | |||||
1 | 132 (4.1) | 44 (4.8) | 36 (3.9) | 31 (3.4) | 21 (2.3) | |
2 | 857 (26.8) | 182 (19.7) | 227 (24.6) | 223 (24.1) | 225 (24.4) | |
3 | 1316 (41.1) | 270 (29.2) | 319 (34.5) | 340 (36.8) | 387 (41.9) | |
4 | 409 (12.8) | 87 (9.4) | 101 (11.0) | 115 (12.4) | 106 (11.4) | |
5 | 487 (15.2) | 108 (11.7) | 120 (13.0) | 130 (14.1) | 129 (14.0) | |
Pathologic ≥ T3a (%) | 823 (22.5) | 176 (19.3) | 223 (24.4) | 210 (22.9) | 214 (23.3) | 0.080 |
